Selective Rev-Erbα/β agonist (IC50
values are 160 and 170 nM for Rev-Erbβ and Rev-Erbα respectively). Exhibits no significant activity against a wide range of nuclear receptors, other receptors, ion channels and transporters at 20 μM. Increases wakefulness, reduces REM and slow wave sleep in vivo
. Also reduces anxiety-like behavior in marble-burying assay. Cell permeable and brain penetrant.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Pharmacological targeting of the mammalian clock regulates sleep architecture and emotional behaviour.
Banerjee et al.
Emerging drugs affecting skeletal muscle function and mitochondrial biogenesis - Potential implications for sports drug testing programs.
Thevis et al.
Rapid Commun. Mass Spectrom, 2016;30:635